GPR52-MODULATORVERBINDUNGEN

European patent · EP4401833 · In force

Register entry

Publication number
EP4401833
Application number
EP22778038
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Sep 15, 2022
Published
Jul 24, 2024
Granted
Oct 22, 2025
Protection ends at the latest
Sep 14, 2042
Next annual fee due
Sep 30, 2027
IPC classes
A61P 25/00 (2006.01)
C07D 401/04 (2006.01)
C07F 9/09 (2006.01)
A61K 31/4439 (2006.01)
Priority
GB 202113186 15.09.2021
PCT application
PCT/GB2022/052328 15.09.2022
PCT publication
WO2023/041909 23.03.2023
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Oct 1, 2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. Sep 2, 2026

    Change

    Published in Swissreg on 02.09.2026

  3. Oct 24, 2025

    Agent entered

    Representative
    Bovard SA, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 24.10.2025

  4. Oct 22, 2025

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.10.2025

Parties

Holder

Nxera Pharma UK Limited

Granta Park Great Abington, Cambridge, Cambridgeshire CB21 6DG, GB

Agent

Bovard AG

Bovard SA

Optingenstrasse 16, 3013 Bern

Inventor

WATSON, Stephen Paul

Cambridge Cambridgeshire CB21 6DG, GB

SWAIN, Nigel Alan

Cambridge Cambridgeshire CB21 6DG, GB

O'BRIEN, Michael Alistair

Cambridge Cambridgeshire CB21 6DG, GB

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.